Sequence-specific m6A demethylation in RNA by FTO fused to RCas9

RNA. 2019 Oct;25(10):1311-1323. doi: 10.1261/rna.070706.119. Epub 2019 Jul 1.

Abstract

N6-methyladenosine (m6A) is the most common internal modification in eukaryotic mRNA and associated with numerous cellular processes in health and disease. Up- and down-regulation of its "writer" or "eraser" proteins alter the global m6A level; however, modifying distinct m6A sites has remained elusive. We genetically fused the dioxygenase FTO responsible for m6A demethylation to RCas9 as an RNA-targeting module. The resulting RCas9-FTO retained demethylation activity and bound to RNA in a sequence-specific manner depending on the sgRNA and PAMmer. Using SCARLET analysis, we quantified the m6A level at a specific site and analyzed the effect of the PAM-to-m6A distance on activity. Sequence-specific demethylation by RCas9-FTO was tested on different RNA combinations and showed up to 15-fold sequence preference for target RNA compared to off-target RNA. Taken together, RCas9-FTO represents a new tool for sequence-specific demethylation of m6A in RNA that can be readily adapted to any given RNA sequence and opens the door to studying the function of distinct m6A sites.

Keywords: Cas9; FTO; N6-methyladenosine (m6A); PAMmer; RNA modification; demethylation; sgRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO / metabolism*
  • CRISPR-Associated Protein 9 / metabolism*
  • Demethylation*
  • Electrophoretic Mobility Shift Assay
  • RNA / metabolism*
  • Recombinant Fusion Proteins / metabolism

Substances

  • Recombinant Fusion Proteins
  • RNA
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • CRISPR-Associated Protein 9